1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Lougheed, J.C. Domaille, P.J. Handel, T.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE J.Biomol.NMR JBNME9 0800 0925-2738 22 211 223 10.1023/A:1014961408029 11991352 Solution structure and dynamics of melanoma inhibitory activity protein. 2002 10.2210/pdb1k0x/pdb pdb_00001k0x 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 12258.138 Melanoma Derived Growth Regulatory Protein 1 man polymer MELANOMA INHIBITORY ACTIVITY no no MGPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYF PSSIVREDQTLKPGKVDVKTDKWDFYCQ MGPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYF PSSIVREDQTLKPGKVDVKTDKWDFYCQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-07-24 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name Crystal structure of melanoma inhibitory activity protein Solution structure of melanoma inhibitory activity protein The author states that an extra MET is at the N-terminus of the sequence that is not present in the native protein due to E. coli expression. The residue numbering in this structure is +1 relative to 1I1J. RCSB Y RCSB 2001-09-21 REL REL structures with the lowest energy 60 20 3D_15N-separated_NOESY 4D_13C/15N-separated_NOESY 3D_13C-separated_NOESY 4D_13C-separated_NOESY 3D_13C-separated_NOESY(centered on aromatic carbons) HNHA 20 mM sodium acetate 4.3 ambient 298 K Restrained molecular dynamics-simulated annealing coupled with the ambiguous restraints for iterative assignment (ARIA) extension of Nilges (M. Nilges, J. Mol. Biol. 245, 645-660, 1995). 1 lowest energy Uniform labeling with 15N 20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 10 % D2O Uniform labeling with 13C and 15N 20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 10 % D2O Uniform labeling with 13C and 15N 20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 100 % D2O Uniform labeling with 13C and 15N 20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 10 % D2O, 2.0 mM EDTA-d12 BRUNGER refinement X-PLOR Brunger structure solution X-PLOR 3.851 P.J. Kraulis data analysis ANSIG 3.3 W. Boucher processing Azara 2.0 600 Bruker DMX MET 1 n 1 MET 1 A GLY 2 n 2 GLY 2 A PRO 3 n 3 PRO 3 A MET 4 n 4 MET 4 A PRO 5 n 5 PRO 5 A LYS 6 n 6 LYS 6 A LEU 7 n 7 LEU 7 A ALA 8 n 8 ALA 8 A ASP 9 n 9 ASP 9 A ARG 10 n 10 ARG 10 A LYS 11 n 11 LYS 11 A LEU 12 n 12 LEU 12 A CYS 13 n 13 CYS 13 A ALA 14 n 14 ALA 14 A ASP 15 n 15 ASP 15 A GLN 16 n 16 GLN 16 A GLU 17 n 17 GLU 17 A CYS 18 n 18 CYS 18 A SER 19 n 19 SER 19 A HIS 20 n 20 HIS 20 A PRO 21 n 21 PRO 21 A ILE 22 n 22 ILE 22 A SER 23 n 23 SER 23 A MET 24 n 24 MET 24 A ALA 25 n 25 ALA 25 A VAL 26 n 26 VAL 26 A ALA 27 n 27 ALA 27 A LEU 28 n 28 LEU 28 A GLN 29 n 29 GLN 29 A ASP 30 n 30 ASP 30 A TYR 31 n 31 TYR 31 A MET 32 n 32 MET 32 A ALA 33 n 33 ALA 33 A PRO 34 n 34 PRO 34 A ASP 35 n 35 ASP 35 A CYS 36 n 36 CYS 36 A ARG 37 n 37 ARG 37 A PHE 38 n 38 PHE 38 A LEU 39 n 39 LEU 39 A THR 40 n 40 THR 40 A ILE 41 n 41 ILE 41 A HIS 42 n 42 HIS 42 A ARG 43 n 43 ARG 43 A GLY 44 n 44 GLY 44 A GLN 45 n 45 GLN 45 A VAL 46 n 46 VAL 46 A VAL 47 n 47 VAL 47 A TYR 48 n 48 TYR 48 A VAL 49 n 49 VAL 49 A PHE 50 n 50 PHE 50 A SER 51 n 51 SER 51 A LYS 52 n 52 LYS 52 A LEU 53 n 53 LEU 53 A LYS 54 n 54 LYS 54 A GLY 55 n 55 GLY 55 A ARG 56 n 56 ARG 56 A GLY 57 n 57 GLY 57 A ARG 58 n 58 ARG 58 A LEU 59 n 59 LEU 59 A PHE 60 n 60 PHE 60 A TRP 61 n 61 TRP 61 A GLY 62 n 62 GLY 62 A GLY 63 n 63 GLY 63 A SER 64 n 64 SER 64 A VAL 65 n 65 VAL 65 A GLN 66 n 66 GLN 66 A GLY 67 n 67 GLY 67 A ASP 68 n 68 ASP 68 A TYR 69 n 69 TYR 69 A TYR 70 n 70 TYR 70 A GLY 71 n 71 GLY 71 A ASP 72 n 72 ASP 72 A LEU 73 n 73 LEU 73 A ALA 74 n 74 ALA 74 A ALA 75 n 75 ALA 75 A ARG 76 n 76 ARG 76 A LEU 77 n 77 LEU 77 A GLY 78 n 78 GLY 78 A TYR 79 n 79 TYR 79 A PHE 80 n 80 PHE 80 A PRO 81 n 81 PRO 81 A SER 82 n 82 SER 82 A SER 83 n 83 SER 83 A ILE 84 n 84 ILE 84 A VAL 85 n 85 VAL 85 A ARG 86 n 86 ARG 86 A GLU 87 n 87 GLU 87 A ASP 88 n 88 ASP 88 A GLN 89 n 89 GLN 89 A THR 90 n 90 THR 90 A LEU 91 n 91 LEU 91 A LYS 92 n 92 LYS 92 A PRO 93 n 93 PRO 93 A GLY 94 n 94 GLY 94 A LYS 95 n 95 LYS 95 A VAL 96 n 96 VAL 96 A ASP 97 n 97 ASP 97 A VAL 98 n 98 VAL 98 A LYS 99 n 99 LYS 99 A THR 100 n 100 THR 100 A ASP 101 n 101 ASP 101 A LYS 102 n 102 LYS 102 A TRP 103 n 103 TRP 103 A ASP 104 n 104 ASP 104 A PHE 105 n 105 PHE 105 A TYR 106 n 106 TYR 106 A CYS 107 n 107 CYS 107 A GLN 108 n 108 GLN 108 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 11 A N LYS 11 A O VAL 98 A O VAL 98 A O PHE 80 A O PHE 80 A N TRP 61 A N TRP 61 A O SER 64 A O SER 64 A N TYR 48 A N TYR 48 A O VAL 49 A O VAL 49 A N SER 23 A N SER 23 A N MET 24 A N MET 24 A O GLN 89 A O GLN 89 1 A TYR 69 -121.47 -70.09 1 A TYR 70 35.25 44.98 1 A ASP 72 -131.70 -91.29 1 A LEU 73 64.93 -78.27 1 A ALA 75 -165.67 -17.26 1 A LEU 77 60.10 176.47 1 A ASP 101 -121.72 -167.77 2 A PRO 5 -49.26 151.19 2 A ARG 56 71.17 -64.66 2 A TYR 69 -119.54 74.84 2 A TYR 70 -147.23 12.72 2 A LEU 73 62.31 -86.02 2 A ALA 75 -152.89 -40.15 2 A LEU 77 61.73 169.33 2 A ASP 88 -147.95 -41.92 2 A LYS 92 -171.28 130.90 2 A LYS 95 -142.97 33.30 3 A TYR 70 -82.53 -129.38 3 A ALA 74 175.08 -14.69 3 A ASP 101 -101.57 -122.03 4 A LEU 7 73.09 -37.96 4 A TYR 69 -136.64 -97.78 4 A ASP 72 -39.16 113.97 4 A LEU 73 -146.96 -39.32 4 A LEU 77 57.79 -179.90 4 A ASP 88 -153.64 -30.69 5 A ARG 56 43.88 25.02 5 A ARG 58 52.05 -74.89 5 A GLN 66 -79.07 -93.94 5 A TYR 69 58.44 93.09 5 A ASP 72 -165.33 -40.53 5 A ARG 76 37.34 82.58 6 A ALA 8 -115.32 -162.92 6 A LEU 73 -153.62 -34.61 6 A ASP 101 -102.29 -112.41 6 A CYS 107 -105.13 52.89 7 A LEU 7 56.39 5.31 7 A ASP 9 -139.44 -53.04 7 A GLN 66 -106.16 76.73 7 A ASP 68 62.95 74.76 7 A LEU 73 -150.73 -50.17 7 A ALA 75 -154.68 -30.94 7 A LEU 77 63.90 139.91 7 A PHE 105 -148.61 58.92 8 A ASP 9 -121.40 -52.17 8 A GLN 66 -31.09 135.30 8 A TYR 69 55.62 75.91 8 A ASP 72 -148.29 35.29 8 A LEU 73 -79.51 -73.09 8 A ALA 75 -146.46 -43.24 8 A LEU 77 65.94 143.59 9 A ASP 72 56.35 80.23 9 A LEU 73 -139.63 -50.98 9 A ALA 74 -94.34 59.77 9 A LEU 77 58.75 178.42 10 A ASP 9 -131.60 -44.28 10 A ASP 72 -152.69 -43.31 10 A LEU 77 40.56 -157.63 11 A LYS 54 -115.40 -133.48 11 A ASP 68 -134.52 -45.61 11 A TYR 69 55.88 84.38 11 A ALA 75 -140.25 -0.42 11 A LEU 77 56.93 104.22 11 A TRP 103 -87.88 45.72 12 A ASP 9 -99.26 -61.22 12 A ASP 68 -148.00 -22.41 12 A TYR 69 76.92 -45.74 12 A TYR 70 57.72 16.51 12 A LEU 73 -155.49 -46.02 13 A LEU 7 76.42 -48.32 13 A ASP 72 61.20 -90.25 13 A LEU 73 62.36 -80.08 13 A TRP 103 -94.38 56.64 13 A ASP 104 -125.76 -51.13 13 A PHE 105 -118.84 63.44 14 A ALA 8 -146.61 -159.46 14 A LYS 54 -112.18 -134.49 14 A ASP 68 62.34 107.93 14 A LEU 73 -151.78 -50.35 14 A ASP 88 -146.84 -30.86 15 A LEU 7 77.64 -46.04 15 A GLN 66 -91.35 -85.17 15 A TYR 69 66.85 -78.97 15 A TYR 70 45.56 26.47 15 A LEU 73 85.38 -47.05 15 A ALA 74 -88.27 40.18 15 A ASP 88 -130.08 -31.81 15 A LYS 92 -170.97 131.01 16 A LEU 7 78.44 -50.92 16 A SER 19 -102.73 41.41 16 A ASP 68 -135.97 -33.04 16 A TYR 69 56.27 87.40 16 A LEU 73 -143.07 -16.10 16 A PHE 105 -151.43 47.94 17 A ASP 9 -101.79 -61.23 17 A ARG 56 42.54 27.86 17 A ASP 68 78.44 78.29 17 A TYR 69 -95.14 -83.88 17 A ASP 72 -165.26 114.26 17 A LEU 73 -159.89 6.22 18 A LYS 54 -131.83 -42.25 18 A ARG 56 58.84 19.09 18 A GLN 66 -74.12 -78.02 18 A ASP 68 67.88 94.11 18 A ASP 72 -148.12 10.66 18 A TRP 103 -88.71 48.01 19 A LEU 7 75.44 -34.39 19 A ASP 9 -129.68 -53.52 19 A LEU 73 -150.17 -24.65 19 A LYS 92 -172.55 135.01 20 A LYS 54 -89.01 -97.26 20 A ARG 56 74.90 -58.26 20 A ARG 58 58.57 -77.37 20 A LEU 73 -134.08 -57.03 20 A TRP 103 -86.75 47.58 Solution Structure of Melanoma Inhibitory Activity Protein 1 N N disulf 2.032 A CYS 13 A SG CYS 13 1_555 A CYS 18 A SG CYS 18 1_555 disulf 2.034 A CYS 36 A SG CYS 36 1_555 A CYS 107 A SG CYS 107 1_555 HORMONE/GROWTH FACTOR SH3 subdomain, HORMONE-GROWTH FACTOR COMPLEX MIA_HUMAN UNP 1 25 Q16674 GPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYFP SSIVREDQTLKPGKVDVKTDKWDFYCQ 25 131 1K0X 2 108 Q16674 A 1 2 108 1 SEE REMARK 999 MET 1 1K0X A Q16674 UNP 1 2 5 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ARG 10 A ARG 10 A CYS 13 A CYS 13 A VAL 96 A VAL 96 A LYS 99 A LYS 99 A GLY 78 A GLY 78 A PRO 81 A PRO 81 A PHE 60 A PHE 60 A GLN 66 A GLN 66 A VAL 46 A VAL 46 A LYS 52 A LYS 52 A SER 23 A SER 23 A ALA 27 A ALA 27 A VAL 85 A VAL 85 A THR 90 A THR 90